Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20081039 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Gabapentin for Smoking Cessation
Conditions: Cigarette Smoking;   Tobacco Use
Interventions: Drug: Placebo;   Drug: Gabapentin - 1800 mg/day;   Drug: Gabapentin - 2700 mg/day

Indicates status has not been verified in more than two years